News Release

Efficacy, safety of atropine for the treatment of pediatric nearsightedness progression over 3 years

JAMA Ophthalmology

Peer-Reviewed Publication

JAMA Network

About The Study: The efficacy and safety observed in this randomized clinical trial suggest that low-dose atropine may provide a treatment option for childhood myopia progression.

Authors: Karla Zadnik, O.D., Ph.D., of the Ohio State University College of Optometry in Columbus, is the corresponding author.

To access the embargoed study: Visit our For The Media website at this link 


Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.